Research
Hormonal
Time-restricted eating (TRE) significantly improves cardiometabolic risk factors, specifically reducing insulin, total cholesterol, and LDL concentrations.
Focus on aligning your eating window with your circadian rhythm (e.g., 16:8). This may improve insulin sensitivity and lipid profiles independently of major weight loss, particularly if you have metabolic risk factors.
ModerateSupportsMEDIUM confidence
Improvements in cardiometabolic risk factors such as a decrease in insulin concentrations [MD: −0.458 mIU/L, (95% CI: −0.843 to −0.073)], total cholesterol [MD: −2.889 mg/dL (95% CI: −5.447 to −0.330) and LDL concentrations [MD: −2.717 mg/dL (95% CI: −4.412 to −1.021)] were observed.
Why this rating
Meta-analysis of 26 studies, but high heterogeneity and moderate risk of bias.
Source
The Effect of Time-Restricted Eating on Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis
Krystalia Panagiotou et al. · Nutrients · 2024
DOI 10.3390/nu16213700
Meta-analysis · 26 studiesCited 10×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →